Patents by Inventor David M. Marquis
David M. Marquis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220048985Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.Type: ApplicationFiled: November 1, 2021Publication date: February 17, 2022Inventors: Yan Chen, Debra Gardner, David M. Knight, Michael W. Lark, Bailin Liang, David M. Marquis, David J. Shealy, Eric Michael Smith, Xiao-yu R. Song, Vedrana Stojanovic-Susulic, Raymond Sweet, Susan Tam, Alain P. Vasserot, Sheng-Jiun Wu, Jing Yang
-
Patent number: 11180549Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.Type: GrantFiled: December 17, 2019Date of Patent: November 23, 2021Assignees: Janssen Biotech, Inc., Applied Molecular Evolution, IncInventors: Yan Chen, Debra Gardner, David M. Knight, Michael W. Lark, Bailin Liang, David M. Marquis, David J. Shealy, Eric Michael Smith, Xiao-yu R. Song, Vedrana Stojanovic-Susulic, Raymond Sweet, Susan Tam, Alain P. Vasserot, Sheng-Jiun Wu, Jing Yang
-
Publication number: 20200115445Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.Type: ApplicationFiled: December 17, 2019Publication date: April 16, 2020Inventors: Yan Chen, Debra Gardner, David M. Knight, Michael W. Lark, Bailin Liang, David M. Marquis, David J. Shealy, Eric Michael Smith, Xiao-yu R. Song, Vedrana Stojanovic-Susulic, Raymond Sweet, Susan Tam, Alain P. Vasserot, Sheng-Jiun Wu, Jing Yang
-
Publication number: 20170253651Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.Type: ApplicationFiled: March 17, 2017Publication date: September 7, 2017Inventors: Yan Chen, Debra Gardner, David M. Knight, Michael W. Lark, Bailin Liang, David M. Marquis, David J. Shealy, Eric Michael Smith, Xioa-yu R. Song, Vedrana Stojanovic-Susulic, Raymond W. Sweet, Susan Tam, Alain P. Vasserot, Sheng-Jiun Wu, Jing Yang
-
Patent number: 9631016Abstract: A pen-injector device comprising an anti-IL-6 antibody with a liquid formulation have applications in diagnostic and/or therapeutic compositions, methods and devices.Type: GrantFiled: April 19, 2016Date of Patent: April 25, 2017Assignees: Janssen Biotech, Inc., Applied Molecular EvolutionInventors: Yan Chen, Debra Gardner, David M. Knight, Michael W. Lark, Bailin Liang, David M. Marquis, David J. Shealy, Eric Michael Smith, Xiao-yu R. Song, Vedrana Stojanovic-Susulic, Raymond W. Sweet, Susan Tam, Alain P. Vasserot, Sheng-Jiun Wu, Jing Yang
-
Publication number: 20160222104Abstract: A pen-injector device comprising an anti-IL-6 antibody with a liquid formulation have applications in diagnostic and/or therapeutic compositions, methods and devices.Type: ApplicationFiled: April 19, 2016Publication date: August 4, 2016Inventors: Yan Chen, Debra Gardner, David M. Knight, Michael W. Lark, Bailin Liang, David M. Marquis, David J. Shealy, Eric Michael Smith, Xiao-yu R. Song, Vedrana Stojanovic-Susulic, Raymond W. Sweet, Susan Tam, Alain P. Vasserot, Sheng-Jiun Wu, Jing Yang
-
Patent number: 9340613Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.Type: GrantFiled: December 4, 2013Date of Patent: May 17, 2016Assignees: Janssen Biotech, Inc., Applied Molecular EvolutionInventors: Yan Chen, Debra Gardner, David M. Knight, Michael W. Lark, Bailin Liang, David M. Marquis, David J. Shealy, Eric Michael Smith, Xiao-yu R. Song, Vedrana Stojanovic-Susulic, Raymond W. Sweet, Susan Tam, Alain P. Vasserot, Sheng-Jiun Wu, Jing Yang
-
Publication number: 20140099311Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.Type: ApplicationFiled: December 4, 2013Publication date: April 10, 2014Applicants: Applied Molecular Evolution, Inc., Janssen Biotech, Inc.Inventors: Yan Chen, Debra Gardner, David M. Knight, Michael W. Lark, Bailin Liang, David M. Marquis, David J. Shealy, Eric Michael Smith, Xiao-Yu R. Song, Vedrana Stojanovic-Susulic, Raymond W. Sweet, Susan H. Tam, Alain P. Vasserot, Sheng-Jiun Wu, Jing Yang
-
Patent number: 8153125Abstract: The present invention relates to CD20 binding molecules and nucleic acid sequences encoding CD20 binding molecules. In particular, the present invention relates to CD20 binding molecules with a high binding affinity, and a low dissociation rate, with regard to human CD20. Preferably, the CD20 binding molecules of the present invention comprise light and/or heavy chain variable regions with fully human frameworks (e.g. human germline frameworks).Type: GrantFiled: May 20, 2004Date of Patent: April 10, 2012Assignee: Applied Molecular Evolution, Inc.Inventors: Jeffry D. Watkins, Julian Davies, David M. Marquis, Barrett W Allan, Brian Ondek
-
Patent number: 6858210Abstract: The present invention provides domain 1 ?2GPI polypeptides, polynucleotides encoding these polypeptides, mimetics of these polypeptides, and methods using domain 1 ?2GPI polypeptides and mimetics. Domain 1 of ?2GPI has been shown to bind to anti-cardiolipin (?2GPI-dependent antiphospholipid) antibodies, which are associated with several pathologies, such as thrombosis and fetal loss. The domain 1 ?2GPI polypeptides may be used to detect ?2GPI-dependent antiphospholipid antibodies in a sample. The invention further provides methods of inducing tolerance using these domain 1 ?2GPI polypeptides.Type: GrantFiled: June 8, 1999Date of Patent: February 22, 2005Assignee: La Jolla Pharmaceutical Co.Inventors: David M. Marquis, Gilbert M. Iverson, Edward J. Victoria, David S. Jones, Matthew D. Linnik
-
Patent number: 5363915Abstract: A method for enhancing the recovery of petroleum from an oil bearing formation during injection of a non-condensible gas comprises the at least periodic injection of a foam forming composition or a preformed foam into the reservoir. The foam which is produced comprises a mixture of a non-condensible gas, water and a non-ionic surfactant. The non-ionic surfactants which can be employed in the present invention are those non-ionic surfactants which have a HLB value of about 14 to less than 20, preferably 15-18, and which provide a stable foam when the surfactant is mixed with brine and/or water and a non-condensible gas. The method is preferably employed within a light oil bearing carbonate formation.Type: GrantFiled: July 2, 1990Date of Patent: November 15, 1994Assignee: Chevron Research and Technology CompanyInventors: David M. Marquis, Donald L. Kuehne
-
Patent number: 5076357Abstract: A method for enhancing the recovery of petroleum from an oil bearing formation during injection of a non-condensible gas comprises the at least periodic injection of a foam forming composition or a preformed foam into the reservoir. The foam comprises a mixture of a non-condensible gas, preferably CO.sub.2, water and an alpha-olefin sulfonate. The alpha-olefin sulfonate comprises a mixture of hydroxy-sulfonates and alkene-sulfonates wherein the ratio of alkene-sulfonates to hydroxy-sulfonates is preferably not greater than about 4. In addition, the hydroxy-sulfonates comprises 3-hydroxy and 4-hydroxy-sulfonates wherein the ratio of 3-hydroxy-sulfonates to 4-hydroxy-sulfonates is at least about 2. The method is preferably employed within a light oil bearing formation comprising sandstone.Type: GrantFiled: May 31, 1990Date of Patent: December 31, 1991Assignee: Chevron Research & Technology CompanyInventor: David M. Marquis
-
Patent number: 4340758Abstract: A process for the preparation of 2,6-dialkylaniline which comprises the reaction of 1,3-dialkylbenzene with isobutene in the presence of a hydrogen fluoride catalyst to form 1,3-dialkyl-5-tertiary-butylbenzene, which is subsequently nitrated in the presence of a soluble mercuric salt catalyst to form 2-nitro-1,3-dialkyl-5-tertiary-butylbenzene, which is then catalytically hydrogenated to give 2,6-dialkyl-4-tertiary-butylaniline, followed by pyrolysis in the presence of a heterogeneous acidic catalyst.Type: GrantFiled: July 6, 1981Date of Patent: July 20, 1982Assignee: Chevron Research CompanyInventors: Seymour J. Lapporte, David M. Marquis
-
Patent number: 4259246Abstract: A process for producing maleic anhydride from a C.sub.4 hydrocarbon selected from n-butane and n-butene feed which comprises: (a) feeding the C.sub.4 hydrocarbon and air to a reactor; (b) contacting the C.sub.4 hydrocarbon and air in the reactor with a catalyst comprising vanadium and phosphorus oxides at reaction conditions including a temperature between 550.degree. and 1000.degree. F. so as to obtain a reactor effluent containing maleic anhydride, unreacted butane, nitrogen, oxygen, and acrylic, acetic or maleic acid or mixtures of the foregoing acids; (c) removing maleic anhydride from the reactor effluent to obtain maleic anhydride-lean effluent; (d) removing said acids from at least a portion of the maleic anhydride-lean effluent to obtain a purified recycle stream containing less than 100 ppm of the acids; and (e) recycling the purified stream to the reactor. Preferably the acids are removed in step (d) by water and/or caustic scrubbing the maleic anhydride-lean effluent.Type: GrantFiled: October 15, 1979Date of Patent: March 31, 1981Assignee: Chevron Research CompanyInventors: Kiran R. Bakshi, David M. Marquis, Stephen G. Paradis
-
Patent number: 4231943Abstract: A process for producing maleic anhydride from n-butane which comprises:(a) feeding n-butane and air to a reactor;(b) contacting the butane and air with a catalyst comprising vanadium and phosphorus oxides at reaction conditions including a temperature between 550.degree. F. and 1000.degree. F. so as to convert 15 to 28% of the butane per pass and obtain a reactor effluent containing maleic anhydride, unreacted butane, nitrogen, and oxygen;(c) removing maleic anhydride from the reactor effluent to obtain maleic anhydride-lean effluent;(d) recycling a portion of the maleic anhydride-lean effluent to the reactor;(e) removing butane from the other portion of the maleic anhydride-lean effluent; and(f) recycling the removed butane to the reactor.Preferably the temperature in, and/or space velocity through, the reactor is adjusted to obtain a weight percent selectivity to maleic anhydride of at least 90% of the butane converted.Type: GrantFiled: May 31, 1979Date of Patent: November 4, 1980Assignee: Chevron Research CompanyInventors: Stephen G. Paradis, David M. Marquis, Kiran R. Bakshi
-
Patent number: 4187235Abstract: A crystalline vanadium (IV) phosphate composition having an intrinsic surface area in excess of 10 square meters per gram is prepared by the reaction of orthophosphoric acid with a vanadium (IV) oxycompound. The vanadium compound is suspended in a suitable hydroxylic organic medium, for example isobutanol, and contacted with the acid at a temperature in the range 20.degree. C. to 210.degree. C. until the conversion is completed. The catalyst is used in the oxidation of n-butane to maleic anhydride.Type: GrantFiled: September 22, 1978Date of Patent: February 5, 1980Assignee: Chevron Research CompanyInventors: Kiyoshi Katsumoto, David M. Marquis
-
Patent number: 4132670Abstract: A crystalline vanadium (IV) phosphate composition having an intrinsic surface area in excess of 10 square meters per gram is prepared by the reaction of orthophosphoric acid with a vanadium (IV) oxycompound. The vanadium compound is suspended in a suitable hydroxylic organic medium, for example isobutanol, and contacted with the acid at a temperature in the range 20.degree. C. to 210.degree. C. until the conversion is completed.Type: GrantFiled: October 6, 1976Date of Patent: January 2, 1979Assignee: Chevron Research CompanyInventors: Kiyoshi Katsumoto, David M. Marquis
-
Patent number: 4071540Abstract: An absorption process for separating a maleic or phthalic anhydride from a gaseous mixture containing the anhydride which comprises contacting the gaseous mixture with a liquid absorbent comprising polymethylbenzophenones, at least a portion of which benzophenones contain at least 3 methyl groups, at a temperature for the absorbent between about 20.degree. and 235.degree. C and at a pressure sufficient to effect absorption of the anhydride into the absorbent. Preferably the absorption process is used to remove maleic anhydride from a gas stream, preferably the absorbent includes dixylylketone, and preferably the absorption is carried out by countercurrent contacting in an absorber column.Type: GrantFiled: August 6, 1976Date of Patent: January 31, 1978Assignee: Chevron Research CompanyInventor: David M. Marquis